An applet for managing cancer patient health interventions
Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients
This study is testing a new mobile app that helps cancer patients and their doctors communicate better to improve care during and after surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 800 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Trial ID | NCT05501990 on ClinicalTrials.gov |
What this trial studies
This study focuses on developing and testing a mobile applet designed for the perioperative management of cancer patients. Utilizing advanced 5G technology, the applet aims to facilitate effective communication between doctors and patients, allowing for better health interventions tailored to the needs of cancer patients. The study will assess the applet's accessibility and feasibility in a general population, aiming to enhance patient management and improve health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients who can use smartphones and have the cognitive ability to engage with the applet.
Not a fit: Patients with specific medical devices like cardiac pacemakers or those who do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this applet could significantly improve the management and prognosis of cancer patients through enhanced communication and tailored interventions.
How similar studies have performed: While the approach of using mobile health technology for cancer care is gaining traction, this specific applet's application and feasibility are novel and have not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Sign and date informed consent; * Commit to abide by the research procedures and cooperate with the implementation of the whole research process ; * Can adhere to and cooperate with research intervention; * Tumor patients; * Patients/family members can use smart phones to access the Internet; * Patients/family members have sufficient cognitive and reading ability; * No mental illness; * No serious visual impairment Exclusion Criteria: * Equipped with specific devices (such as cardiac pacemaker); * Those who do not meet the conditions listed in the inclusion criteria.
Where this trial is running
Shanghai
- Ruijin Hospital，Shanghai Jiao Tong University School of Medicine — Shanghai, China (Recruiting)
Study contacts
- Principal investigator: Lei Huang, PhD, MD — Ruijin Hospital
- Study coordinator: Lei Huang, PhD, MD
- Email: huangleizhenting@126.com
- Phone: 0086 021 64370045
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.